Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-03-22 @ 6:46 AM
Study NCT ID:
NCT00063895
Status:
COMPLETED
Last Update Posted:
2013-01-09
First Post:
2003-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2003-07-08
First Submit QC Date:
None
Study First Post Date:
2003-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-08
Last Update Post Date:
2013-01-09
Last Update Post Date Type:
ESTIMATED